{"paper_id":"c7651efc-1050-497b-a224-7aac1750a959","body_text":"概要\n目的\n探讨人类端粒酶逆转录酶 (h-TERT) 和 Ki-67 与子宫内膜异位症复发的相关性.\n创新点\n第一次将 h-TERT 和 Ki-67 联合表达水平可作为卵巢子宫内膜异位症复发的有用预测标志物.\n方法\n收集 30 例术后 30 个月复发的卵巢子宫内膜异位症患者、 30 例术后 30 个月未复发的卵巢子宫内膜异位症患者和 30 例对照组的子宫内膜异位症组织样本. 采用免疫组织化学方法检测异位子宫内膜组织中 h-TERT 和 Ki-67 的表达.\n结论\nh-TERT 和 Ki-67 联合表达水平可作为卵巢子宫内膜异位症复发的有用预测标志物, 子宫内膜 h-TERT 过度表达以及术后血清 CA125 水平升高可能在卵巢子宫内膜异位症复发中起重要作用.\nReferences\nAlnafakh RAA, Adishesh M, Button L, et al., 2019. Telomerase and telomeres in endometrial cancer. Front Oncol, 9:344. https://doi.org/10.3389/fonc.2019.00344\nBozdag G, 2015. Recurrence of endometriosis: risk factors, mechanisms and biomarkers. Women’s Health, 11(5): 693–699. https://doi.org/10.2217/whe.15.56\nBubendorf L, Sauter G, Moch H, et al., 1996. Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy. J Pathol, 178(4): 437–441. https://doi.org/10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4\nCeccaroni M, Bounous VE, Clarizia R, et al., 2019. Recurrent endometriosis: a battle against an unknown enemy. Eur J Contracept Reprod Health Care, 24(6):464–474. https://doi.org/10.1080/13625187.2019.1662391\nChapron C, Marcellin L, Borghese B, et al., 2019. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol, 15(11):666–682. https://doi.org/10.1038/s41574-019-0245-z\nChiang HJ, Lin PY, Huang FJ, et al., 2015. The impact of previous ovarian surgery on ovarian reserve in patients with endometriosis. BMC Women’ s Health, 15:74. https://doi.org/10.1186/s12905-015-0230-1\nde Ziegler D, Borghese B, Chapron C, 2010. Endometriosis and infertility: pathophysiology and management. Lancet, 376(9742):730–738. https://doi.org/10.1016/S0140-6736(10)60490-4\nDing L, Zhou YX, He C, et al., 2020. Elevated CA125 levels are associated with adverse clinical outcomes in acute pancreatitis: a propensity score-matched study. Pancreatology, 20(5):789–794. https://doi.org/10.1016/j-pan.2020.06.009\nGreene AD, Lang SA, Kendziorski JA, et al., 2016. Endometriosis: where are we and where are we going? Reproduction, 152(3):R63–R78. https://doi.org/10.1530/REP-16-0052\nHanege BY, Çekiç SG, Ata B, 2019. Endometrioma and ovarian reserve: effects of endometriomata per se and its surgical treatment on the ovarian reserve. Facts Views Vis Obgyn, 11(2): 151–157.\nHannen R, Bartsch JW, 2018. Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasis. FEBS Lett, 592(12):2023–2031. https://doi.org/10.1002/1873-3468.13084\nHu CJ, Ni ZH, Li BS, et al., 2017. hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation. Gut, 66(1): 31–42. https://doi.org/10.1136/gutjnl-2015-309322\nKajiyama H, Suzuki S, Yoshihara M, et al., 2019. Endometriosis and cancer. Free Radic Biol Med, 133:186–192. https://doi.org/10.1016/j.freeradbiomed.2018.12.015\nKalaitzopoulos DR, Mitsopoulou A, Iliopoulou SM, et al., 2020. Association between endometriosis and gynecological cancers: a critical review of the literature. Arch Gynecol Obstet, 301(2):355–367. https://doi.org/10.1007/s00404-020-05445-1\nKoga K, Takamura M, Fujii T, et al., 2015. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril, 104(4):793–801. https://doi.org/10.1016/j.fertnstert.2015.08.026\nLaganà AS, Garzon S, Götte M, et al., 2019. The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci, 20(22):5615. https://doi.org/10.3390/ijms20225615\nLi CH, Wang CH, 2021. LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(8): 633–646. https://doi.org/10.1631/jzus.B2000797\nLi LT, Jiang G, Chen Q, et al., 2015. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep, 11(3):1566–1572. https://doi.org/10.3892/mmr.2014.2914\nLi XY, Chao XP, Leng JH, et al., 2019. Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women. J Ovarian Res, 12:79. https://doi.org/10.1186/s13048-019-0552-y\nLi Y, Li RQ, Ouyang NY, et al., 2019. Investigating the impact of local inflammation on granulosa cells and follicular development in women with ovarian endometriosis. Fertil Steril, 112(5):882–891.e1. https://doi.org/10.1016/j.fertnstert.2019.07.007\nLiu SP, Xin WJ, Tang XY, et al., 2020. LncRNA H19 over-expression in endometriosis and its utility as a novel biomarker for predicting recurrence. Reprod Sci, 27(9): 1687–1697. https://doi.org/10.1007/s43032-019-00129-x\nMcPeak AE, Allaire C, Williams C, et al., 2018. Pain catastrophizing and pain health-related quality-of-life in endometriosis. Clin J Pain, 34(4):349–356. https://doi.org/10.1097/AJP.0000000000000539\nMiller I, Min MW, Yang C, et al., 2018. Ki67 is a graded rather than a binary marker of proliferation versus quiescence. Cell Rep, 24(5):1105–1112.e5. https://doi.org/10.1016/j.celrep.2018.06.110\nPark JS, Lee JH, Kim M, et al., 2009. Endometrium from women with endometriosis shows increased proliferation activity. Fertil Steril, 92(4):1246–1249. https://doi.org/10.1016/j.fertnstert.2009.04.025\nPoole JC, Andrews LG, Tollefsbol TO, 2001. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene, 269(1–2):1–12. https://doi.org/10.1016/s0378-1119(01)00440-1\nRolla E, 2019. Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment. F1000Research, 8:529. https://doi.org/10.12688/f1000research.14817.1\nSakamoto Y, Harada T, Horie S, et al., 2003. Tumor necrosis factor-α-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-κB activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression. J Clin Endocrinol Metab, 88(2):730–735. https://doi.org/10.1210/jc.2002-020666\nSocolov R, Socolov D, Sindilar A, et al., 2017. An update on the biological markers of endometriosis. Minerva Ginecol, 69(5):462–467. https://doi.org/10.23736/S0026-4784.17.04046-1\nTurk DC, 2002. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain, 18(6):355–365. https://doi.org/10.1097/00002508-200211000-00003\nVercellini P, Viganò P, Somigliana E, et al., 2014. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol, 10(5): 261–275. https://doi.org/10.1038/nrendo.2013.255\nAcknowledgments\nThis work was supported by the Natural Science Foundation of Zhejiang Province (No. LGF20H040009), China.\nAuthor information\nAuthors and Affiliations\nContributions\nJie LUO, Jun LIN, and Jianhong ZHOU conceived the study, participated in its design and coordination, and helped to draft the manuscript. Zhimin SONG carried out the immunohistochemistry studies and drafted the manuscript. Tao ZHANG and Ketan CHU were involved in clinical data collection and data analysis, and Jingyi LI was involved in revising the manuscript. All authors have read and approved the final manuscript, and therefore, take responsibility for the integrity of the study.\nCorresponding authors\nEthics declarations\nJie LUO, Zhimin SONG, Tao ZHANG, Ketan CHU, Jingyi LI, Jianhong ZHOU, and Jun LIN declared that they have no conflict of interests.\nThe study was approved by the Human Ethics Committee of Women’s Hospital, Zhejiang University School of Medicine (No. 20190014), China. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study. Additional informed consent was obtained from all patients for whom identifying information is included in this article.\nAdditional information\nMaterials and methods\nDetailed methods are provided in the electronic supplementary materials of this paper.\nSupplementary information\nMaterials and methods\nSupplementary information\nRights and permissions\nAbout this article\nCite this article\nLuo, J., Song, Z., Zhang, T. et al. Upregulation of h-TERT and Ki-67 in ectopic endometrium is associated with recurrence of endometriosis. J. Zhejiang Univ. Sci. B 23, 158–163 (2022). https://doi.org/10.1631/jzus.B2100502\nReceived:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1631/jzus.B2100502","source_license":"CC0","license_restricted":false}